Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey. Show more

Location: 2 Headquarters Plaza, Morristown, NJ, 07960, United States | Website: https://ir.whitehawktx.com | Industry: Biotechnology | Sector: Healthcare

Market Cap

101.3M

52 Wk Range

$1.39 - $3.81

Previous Close

$2.15

Open

$2.18

Volume

46,712

Day Range

$2.10 - $2.29

Enterprise Value

-57.97M

Cash

162.6M

Avg Qtr Burn

-23.81M

Insider Ownership

12.43%

Institutional Own.

67.27%

Qtr Updated

09/30/25

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
HWK-007 Details NSCLC, ovarian, endometrial cancers	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.